Recent Posts
- Cell2Cure has received approval from the Danish Medicinal Agency for a clinical Phase I study
- The Cell2Cure core technology has been granted patent rights in Australia
- Patient enrollment finalized in the Phase II trial testing ASC in Sjögren’s syndrome
- Publication of phase I results of ASC treatment of patients with radiation-induced Xerostomia
- Cell2Cure enters into a collaboration agreement with Endeavour Cells ApS
Recent Comments